A detailed history of Trust Point Inc. transactions in Repligen Corp stock. As of the latest transaction made, Trust Point Inc. holds 7,534 shares of RGEN stock, worth $1.06 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
7,534
Previous 5,976 26.07%
Holding current value
$1.06 Million
Previous $1.1 Billion 13.59%
% of portfolio
0.08%
Previous 0.09%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

BUY
$120.0 - $182.95 $186,960 - $285,036
1,558 Added 26.07%
7,534 $950 Million
Q1 2024

Apr 19, 2024

BUY
$170.78 - $208.42 $293,229 - $357,857
1,717 Added 40.31%
5,976 $1.1 Billion
Q4 2023

Jan 23, 2024

BUY
$114.17 - $185.35 $486,250 - $789,405
4,259 New
4,259 $766 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.81B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Trust Point Inc. Portfolio

Follow Trust Point Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust Point Inc., based on Form 13F filings with the SEC.

News

Stay updated on Trust Point Inc. with notifications on news.